Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.69 | N/A |
| PEG Ratio (TTM) | -0.72 | N/A |
| P/S Ratio (TTM) | 0.58 | N/A |
| P/B Ratio (TTM) | 0.78 | N/A |
| P/FCF Ratio (TTM) | 5.27 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.33% | N/A |
| ROE (TTM) | 3.48% | N/A |
| Net Profit Margin (TTM) | 2.55% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 118.59% | 3,349.65% | N/A |
| Revenue | -3.18% | 80.50% | N/A |
| Net Income | 122.99% | 1,892.03% | N/A |
| Cash Flow | -18.68% | 310.44% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.93 | N/A |
| Quick Ratio (TTM) | 1.17 | N/A |
| D/E Ratio (TTM) | 1.20 | N/A |
| Interest Coverage (TTM) | 1.18 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.31 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |